Decline in Left Ventricular Early Systolic Function with Worsening Kidney Function in Children with CKD: Insights from the 4C and HOT-KID Studies

INTRODUCTION: Adults with childhood-onset chronic kidney disease (CKD) have increased risk of cardiovascular disease. First-phase ejection fraction (EF1) a novel measure of early systolic function may be a more sensitive marker of left ventricular dysfunction than other markers in children with CKD....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Society of Echocardiography 2023-11
Hauptverfasser: Gu, Haotian, Azukaitis, Karolis, Doyon, Anke, Erdem, Sevcan, Ranchin, Bruno, Harambat, Jerome, Lugani, Francesca, Boguslavskyi, Andrii, Cansick, Janette, Finlay, Eric, Gilbert, Rodney, Kerecuk, Larissa, Lunn, Andrew, Maxwell, Heather, Morgan, Henry, Shenoy, Mohan, Shroff, Rukshana, Subramaniam, Pushpa, Tizard, Jane, Tse, Yincent, Simpson, John, Chowienczyk, Phil, Schaefer, Franz, Sinha, Manish D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:INTRODUCTION: Adults with childhood-onset chronic kidney disease (CKD) have increased risk of cardiovascular disease. First-phase ejection fraction (EF1) a novel measure of early systolic function may be a more sensitive marker of left ventricular dysfunction than other markers in children with CKD. OBJECTIVE: To examine whether EF1 is reduced in children with CKD. METHODS: Children from 4C and HOT-KID studies were stratified according to estimated glomerular filtration rate (eGFR). EF1 was calculated from the fraction of LV volume ejected up to the time of peak aortic flow velocity. RESULTS: EF1 was measured in children aged 10.9±3.7 (mean±SD) years, 312 with CKD and 63 healthy controls. EF1 was lower, whilst overall EF was similar in those with CKD compared to controls and decreased across stages of CKD (29.3±3.7%, 23.5±4.5%, 19.8±4.0%, 18.5±5.1% and 16.7±6.6% in controls, CKD 1, 2, 3 and ≥4, respectively, p
ISSN:0894-7317
1097-6795
DOI:10.1016/j.echo.2023.11.013